The Prostate Cancer Program is uniquely positioned to make historic advancements in the prevention, research and treatment of prostate cancer.
A multi-disciplinary team of medical oncologists, radiation oncologists, urologic oncologists, pathologists, radiologists, nurses, social workers, nurse navigators, and researchers, are united in one goal - eradicating prostate cancer. To reach that goal, we have created a prostate cancer research and treatment program of extraordinary quality. It is a place where research discoveries are applied to prevention and treatment, and where compassionate care is given to patients, their families and friends. Cutting-edge clinical trials are a central component of the Prostate Cancer Program.
Our physicians see patients here in New Brunswick as well as at Monmouth Medical Center, an RWJBarnabas Health facility, and at Rutgers Cancer Institute of New Jersey at University Hospital.
Rutgers Cancer Institute of New Jersey is a leader in laparoscopic renal procedures and has extensive experience with robotic prostatectomy. The major advantages of robotic prostatectomy include shorter hospital stays, lower blood loss, and faster recovery. Given that robotic surgery is a relatively new technology, surgeon experience is critical for good outcome. Under the leadership of the Urologic Oncology Program, Rutgers Cancer Institute of New Jersey has developed a center of excellence for robotic surgery and its urologic oncologists have performed more than 2,000 robotic prostatectomies. Dr. Isaac Kim, chief of the Section of Urologic Oncology, has also developed a new surgical technique for nerve sparing (Athermal Intrafascial Robotic Prostatectomy or AIR prostatectomy) using the robot that leads to faster recovery of sexual function as well as bladder control.